top of page
Eysuvis (loteprednol etabonate ophthalmic suspension) 0.25% is an eye drop that is used for up to two weeks to treat signs and symptoms ofdry eye disease. Fact Table Formula C24H31ClO7 License US FDA Bioavailability None Legal status Rx-Only Chemical Name Loteprednol etabonate Elimination half-life 2.8 hrs Dosage (Strength) 0.25% 8.3ml Pregnancy Consult Doctor Brands Eysuvis Protein binding 95% PubChem CID 444025 MedlinePlus a619025 ChEBI 31784 ATC code S01BA14 DrugBank DB14596 KEGG D01689 Routes of administration Eye drops

Eysuvis (Loteprednol Etabonate Ophthalmic Suspension)

  • Eysuvis is an eye drop suspension that contains 2.5 mg/mL of loteprednol etabonate. Follow the instructions that come with your Eysuvis prescription. Talk to your doctor or pharmacist about any questions or concerns you have about your prescription. Before using Eysuvis, wash your hands thoroughly. To prevent contamination, keep the dropper tip from touching surfaces. Shake the bottle for 2 to 3 seconds. Place one to two drops into each eye four times a day. Wait at least 5 minutes between using Eysuvis and other eye drops. Remove contact lenses before using Eysuvis. You may reinsert them 15 minutes after using Eysuvis.
bottom of page